ABOMICS

Abomics Ltd is an expert company that promotes the application of medical research to patient care. The focus is on genetic as well as the efficacy and safety of medicinal products associated with utilization of new knowledge. The company was founded in 2013, and the office is located in Turku Science Park in the premises. Abomics Oy employs various special disciplines: genetics, genetics, molecular medicine, medical information technology and software development. Processing and interpretat... ion of the results of genetic tests is knowledge-intensive activities, which already has a real demand both within the borders of Finland and the international market. Health care is generally identified as a problem between the drugs efficacy and safety of variation in individuals. Exploitation of genome information in health care allows the individual to inherit according to a tailor-made care package. The person tailored and individualized therapy is proven to be safer and more efficient. In addition, the public sector have a significant savings, for example. through the reduction of adverse effects of medicines. It is essential to provide the best possible tools of genome data utilization in health care. Abomics working on a complex genome data into a format that anyone, whether a physician or an ordinary citizen, understands and is able to read it. Because the genome is every human being personal and unchangeable, knowledge can and should be used as a preventive measure. When the genomic information used in the selection of treatment the whole decision support, provide the best outcomes for patients. Abomics is two years developing tools for decision support for health professionals. These tools include the individual drugs, genetic variation already taken into account in the selection of a preventive drug therapy becomes possible. In addition, the company has two services for the consumer, my medicine and Geenitaltio , the purpose of which is to bring genome information available to everyone, easy to understand format. Abomics has evolved over half a decade into a significant player in the sector with a broad network of partners to cover a number of EU countries, and can reach up to Japan. The idea for the establishment of Abomicsin began when two old friends in tennis, Jari Forsstrรถm and Klaus Elenius, discussed the tennis hall in the sauna on the future of health care. Both were sure that the patient's own genome and genetic testing is going to be the cornerstone of future individualized treatment. Scientific research in medical genomics knowledge of the benefits already had strong evidence, but in practical applications were few and far between. As long as the health professionals did not have available valid tools to exploit genome information, the case would not progress. So they decided to set up a business in this widely recognized to solve the problem. Abomicsin The basic idea is to bring information based on solid scientific evidence, understandable way for the doctor than the patient.
ABOMICS
Industry:
Biotechnology Health Care Medical
Founded:
2013-01-01
Address:
Turku, Western Finland, Finland
Country:
Finland
Website Url:
http://www.abomics.fi
Total Employee:
1+
Status:
Active
Contact:
+358503632200
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon Content Delivery Network Nginx Microsoft Exchange Online
Newest Events participated

Official Site Inspections
http://www.abomics.fi
- Host name: magee.hostaan.shop
- IP address: 94.237.32.206
- Location: Finland
- Latitude: 60.1717
- Longitude: 24.9349
- Timezone: Europe/Helsinki

More informations about "Abomics"
About us - Abomics
About us Abomics Oy is a Finnish company specialised in offering tools to support doctorsโ decision-making. We promote applying knowledge gained โฆSee details»
Home - Abomics
Abomics collaborates with clinical laboratories to offer a pharmacogenetic test and interpretation report that helps doctors prescribe a medication and dosage โฆSee details»
Merger of Abomics and Multirec Effective from Early 2025
As of January 1, 2025, Abomics Oy and Multirec Oy have merged their operations. This union brings together the expertise of two industry leaders, enabling the combined organization to โฆSee details»
Abomics Company Profile | Management and Employees List
Abomics provides solutions to help organizations tackle the challenges of applied genomic. Abomics was founded in 2013 in Turku, Finland by two medical doctors Jari Forsström and โฆSee details»
Abomics - Crunchbase Company Profile & Funding
Abomics Ltd is an expert company that promotes the application of medical โฆSee details»
Abomics Ltd - suomenbioteollisuus.fi
Tykistökatu 4 B, FI-20520 TurkuYrityksen profiili Abomics was founded in 2013 and itโs located in Turku, Finland. The company employs experts specialised in medicine, genetics, โฆSee details»
Abomics | LinkedIn
Abomics | 1 071 followers on LinkedIn. Clinically actionable pharmacogenetics for personalized care. | Abomics is a Finnish health technology company founded in 2013 by medical doctors โฆSee details»
Abomics - Overview, News & Similar companies | ZoomInfo.com
View Abomics (www.abomics.fi) location in Southwest Finland, Finland , revenue, industry and description. Find related and similar companies as well as employees by title and much more.See details»
Abomics - VentureRadar
The goal of Abomics is to answer this need by maintaining databases of genetic information in an easy-to-use and constantly up-dated format. These databases can be implemented in โฆSee details»
Abomics Oy | LinkedIn
Abomics Oy | 1 053 followers on LinkedIn. Supporting medication decisions. | Precision medicine is available for your patients today. Pharmacogenetics is the science that combines genetics โฆSee details»
Abomics (company) | Nordic 9
Abomics (company). Abomics Ltd is a Finnish health technology company that provides healthcare professionals with new approaches to personalised medicine as it specialises in โฆSee details»
Abomics Oy: Contact Details and Business Profile - RocketReach
Abomics Oy is a Business Services, Hospitals and Health Care, and Medical company located in Turku with $5.00 Million in revenue and 13 employees. Find top employees, contact details โฆSee details»
Abomics Oy:Company Profile & Technical Research,Competitor โฆ
Abomics is a company that provides Health care, Genome and more. Abomics is headquartered in Finland Western Finland. Abomics was founded in 2013.See details»
Abomics Oy Company Profile | TURKU, Varsinais-Suomi, Finland ...
Find company research, competitor information, contact details & financial data for Abomics Oy of TURKU, Varsinais-Suomi. Get the latest business insights from Dun & Bradstreet.See details»
Abomics Company Profile - Office Locations, Competitors ... - Craft
Abomics has 5 employees at their 1 location. See insights on Abomics including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Abomics - F6S
Abomics - Abomics Ltd is a specialist company in genetic information. Our focus is on leveraging the new knowledge acquired from genomic information, and applying it into clinical practice.See details»
Abomics Oy - yritystiedot, Y-tunnus ja päättäjät
Katso b2b.profinder.fi:stä yrityksen/yhteisön Abomics Oy tarkemmat yritystiedot, toimipaikat, päättäjät, henkilöstö, taloustiedot (liikevaihto, liikevaihdon muutos, tulos), toimialat, โฆSee details»
Abomics - yritystiedot, päättäjät, taloustiedot | Finder
Finder kertoo Abomics yrityksestä kaiken olennaisen. Tutki yritystietoja, taloustietoja, päättäjätietoja ja tulosta.See details»
Abomics Oy - Jobly.fi
Abomics is a Finnish expert company that empowers physicians with tools for informed decision-making. Our focus lies in the field of personalized health care, specifically pharmacogenetics.See details»
Abomics Oy Management Team | Org Chart - RocketReach
Abomics Oy employs 15 employees. The Abomics Oy management team includes Jari Forsström (Chief Medical Officer), Mikko Inkinen (), and Kari Antila (Board Member).See details»